These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30381616)

  • 1. Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells.
    Kikuchi N; Ye J; Hirakawa J; Kawashima H
    Biol Pharm Bull; 2019 Jan; 42(1):57-65. PubMed ID: 30381616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo.
    Wennerberg E; Kremer V; Childs R; Lundqvist A
    Cancer Immunol Immunother; 2015 Feb; 64(2):225-35. PubMed ID: 25344904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
    Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.
    Sorski L; Melamed R; Matzner P; Lavon H; Shaashua L; Rosenne E; Ben-Eliyahu S
    Brain Behav Immun; 2016 Nov; 58():91-98. PubMed ID: 27235931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.
    Meijer J; Zeelenberg IS; Sipos B; Roos E
    Cancer Res; 2006 Oct; 66(19):9576-82. PubMed ID: 17018614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of liver metastases through perioperative acute CpG-C immune stimulation.
    Sorski L; Melamed R; Levi B; Matzner P; Lavon H; Rosenne E; Shaashua L; Ricon I; Sandbank E; Benbenishty A; Ben-Eliyahu S
    Cancer Immunol Immunother; 2020 Oct; 69(10):2021-2031. PubMed ID: 32405793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis.
    Kollmar O; Scheuer C; Menger MD; Schilling MK
    Ann Surg Oncol; 2006 Feb; 13(2):263-75. PubMed ID: 16424980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
    Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
    Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors.
    Kurzejamska E; Sacharczuk M; Landázuri N; Kovtonyuk O; Lazarczyk M; Ananthaseshan S; Gaciong Z; Religa P
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
    Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
    Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.
    Wang XY; Li Y; Manjili MH; Repasky EA; Pardoll DM; Subjeck JR
    Cancer Immunol Immunother; 2002 Aug; 51(6):311-9. PubMed ID: 12111119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.
    Li G; Tian L; Hou JM; Ding ZY; He QM; Feng P; Wen YJ; Xiao F; Yao B; Zhang R; Peng F; Jiang Y; Luo F; Zhao X; Zhang L; Zhou Q; Wei YQ
    Clin Cancer Res; 2005 Jun; 11(11):4217-24. PubMed ID: 15930360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A mechanistic study of radiotherapy on intratumoral NK cell infiltration augmentation by regulating the EZH2/CXCL10 pathway in hepatocellular carcinoma cells].
    Zhao XF; Wang Q; Sun J; Zhang AM; Chang XY; Li WG; Duan XZ
    Zhonghua Gan Zang Bing Za Zhi; 2024 Sep; 32(9):835-844. PubMed ID: 39375105
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of Caspy2 and IP-10 gene therapy significantly improves therapeutic efficacy against murine malignant neoplasm growth and metastasis.
    Zhang N; Yang Y; Cheng L; Zhang XM; Zhang S; Wang W; Liu SY; Wang SY; Wang RB; Xu WJ; Dai L; Yan N; Fan P; Dai LX; Tian HW; Liu L; Deng HX
    Hum Gene Ther; 2012 Aug; 23(8):837-46. PubMed ID: 22548488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.
    Bugide S; Gupta R; Green MR; Wajapeyee N
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
    Wang D; Jiang W; Zhu F; Mao X; Agrawal S
    Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.